Pandemic Flu, MERS-CoV, Ebola! What's next? What are we doing about emerging infections?

Similar documents
Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update

BC MHOs, PHNLs, ICPs, ERDOCs, IDSPEC, MEDMICRO, AMBULANCE, BCCDC Internal Groups, National Surveillance Network Partners

Emerging TTIs How Singapore secure its blood supply

Emerging Pathogens that Impact the Canadian Blood Supply Alberta Vein to Vein Conference March 18-19, 2016

CAA Meeting COMMUNICABLE DISEASE CONTROL. 20 July 2016


Emerging global health threats of animal origin

Guidance for Travelers on Temporary Work Assignment Abroad

Preventing disease Promoting and protecting health

Issue No. 9, December 2013

HPAI H5(N8) in Member States in poultry, captive and wild birds

HEV Update Blood Components. Dragoslav Domanović, European Centre for Disease Prevention and Control (Sweden)

Situation update pandemic (H1N1) 2009

Surveillance Report 2014

8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 2013 (covering week )

How to respond to emerging transfusiontransmissible

MERS. G Blackburn DO, MACOI Clinical Professor of Medicine MSUCOM

ZIKA VIRUS. Causes, Symptoms, Treatment and Prevention

Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 st January 2015 (covering week )

Donation Criteria for Men who have Sex with Men (MSM): Update from Canadian Blood Services

دکتر بهروز نقیلی استاد بیماریهای عفونی مرکس تحقیقات بیماریهای عفونی و گرمسیری پاییس 88

2014 Surveillance Report. Transfusion-transmissible infections in Australia

OIE Situation Report for Avian Influenza

MERS H7N9. coronavirus. influenza virus. MERS: Since September 2012: 160 cases, including 68 deaths (42%)

Influenza Weekly Surveillance Bulletin

INFLUENZA SURVEILLANCE

Cough, Cough, Sneeze, Wheeze: Update on Respiratory Disease

Zika Virus. Report to the Standing Committee on Health. Dr. Graham Sher Chief Executive Officer, Canadian Blood Services

Infections What is new and what is important?

Surveillance Report 2015

Chapter 38 Viral Infections

Viruses: Select Agents and Emerging Pathogens. Patricia Bolívar MS., CLS, PHM

Influenza at the human-animal interface

Pandemic Preparedness

Department of Defense Armed Forces Health Surveillance Branch Global MERS-CoV Surveillance Summary (16 NOV 2016)

European Centre for Disease Prevention and Control. Zika virus disease

EVALUATION OF HEALTH THREATS: How the EU system functions Zsuzsanna Jakab, Director of ECDC, Informal Meeting of Health Ministers

ZIKA VIRUS. John J. Russell MD May 27, 2016

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Avian Influenza

Field research to iden/fy infec/ous agents in animals and the environment to a6empt to predict emergence

Outbreak Investigation Guidance for Vectorborne Diseases

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

NCCID RAPID REVIEW. 1. What are the case definitions and guidelines for surveillance and reporting purposes?

EDUCATIONAL COMMENTARY EMERGING INFECTIOUS DISEASE AGENTS

What is Zika virus (Zika)?

Main developments in past 24 hours

Preparedness plan against Chikungunya and dengue dissemination in mainland France Public Health perspective

Measles and rubella monitoring January 2015

Influenza Pandemic (H1N1) 2009

5.4.8 Pandemic Disease

Department of Defense Armed Forces Health Surveillance Branch Global MERS-CoV Surveillance Summary (14 DEC 2016)

HPS Monthly National Seasonal Respiratory Report

Distribution: As Appendix 1 Dr Ruth Hussey, Chief Medical Officer, Welsh Government Date: 10 October Ongoing Ebola outbreak in West Africa

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Current Situation on Avian Influenza and the pandemic threat

UPDATE ON INFECTIOUS DISEASES 2015

Weekly Influenza Surveillance Report. Week 11

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Influenza A(H1N1)2009 pandemic Chronology of the events in Belgium

WHAT S INFECTIOUS and HOT: 2014

Importància clínica dels nous virus emergents: grip i coronavirus

OIE Situation Report for Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza

Pandemic Influenza: Global and Philippine Situation

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

Human Cases of Swine Influenza in California, Kansas, New York City, Ohio, Texas, and Mexico Key Points April 26, 2009

Influenza Weekly Surveillance Bulletin

Emerging respiratory infections: MERS and beyond. Victoria Johnston Hospital for Tropical Diseases

West Nile Disease. World situation and impact on public health

Communicable diseases in the Mediterranean region

Establishment of networks of human and animal virology laboratories and medical entomology

Viral Pneumonia: much more than what is diagnosed Filipe Froes

Virology vigilance - an update on MERS and viral mutation and epidemiology for family doctors

Mosquito Threats in LA County West Nile virus & Zika

Emerging Infectious Disease Categories (NIAID) 1 of 3

CURRENT PERSPECTIVES ON TRANSFUSION-TRANSMITTED INFECTIOUS DISEASES: EMERGING PATHOGENS WORLDWIDE

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

Towards Integrated Syndromic Surveillance in Europe?

Official Journal of the European Union

How to design intranational deferral Malaria in Greece

Outbreaks of Zika Virus: What Do We Know? Presented by Dr Jonathan Darbro Mosquito Control Lab, QIMR Berhgofer 15 September 2016

International experience. Local knowledge.

DENGUE AND BLOOD SAFETY. Ester C Sabino, MD, PhD Dep. of Infectious Disease/Institute of Tropical Medicine University of São Paulo

When infections go viral Zika Virus

Pathogen Safety and BSE / variant CJD

Influenza Weekly Surveillance Bulletin

Update on Transfusion- Transmitted Infectious Diseases

Travel Health Alert. Argentina Over 79,400 probable cases (10 deaths) of dengue fever have been reported from 21 provinces during 2016.

A RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA

Summary of current outbreak in Guinea, Liberia and Sierra Leone

OIE Situation Report for Highly Pathogenic Avian Influenza

Influenza Weekly Surveillance Bulletin

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

Influenza Update N 176

Middle East Respiratory Syndrome (MERS): Is It a Health Emergency?

Avian influenza - current situation and future trends

OIE Situation Report for Avian Influenza

SPECIALIZED FAMILY CARE Provider Training

Transcription:

Pandemic Flu, MERS-CoV, Ebola! What's next? What are we doing about emerging infections? BBTS 2014 Claire Reynolds, Scientist NHS Blood and Transplant / Public Health England Epidemiology Unit

Pandemic Flu! 2009 WHO declared H1N1 swine flu outbreak a PHEIC, >15,000 deaths by Feb 2010 The only thing certain about influenza viruses is that nothing is certain. 1. What are we doing about emerging infection? BBTS 2014 WHO Evolution of a pandemic: A(H1N1) 2009, April 2009 August 2010 2nd ed.

MERS-CoV! 2012 to present Respiratory syndrome: asymptomatic Starts with fever, cough can lead to severe pneumonia with ARDS, septic shock, multi-organ failure & death. Over 850 cases in over 20 countries: 40% CFR In Europe, 6 countries have reported confirmed cases, all with a connection with the Middle East. 2. What are we doing about emerging infection? BBTS 2014

Ebola! 2014 Haemorrhagic virus: fever, D&V, bleeding, death. 4,388 cases (2,226 deaths) 1st outbreak West Africa Largest outbreak, affecting densely populated urban areas. 8 August 2014, WHO declared a PHEIC. Currently rapidly increasing. Fruit bats are seen for sale at a food market in Brazzavile, Republic of Congo, December 15, 2005. Credit: Reuters/Jiro Ose. 3. What are we doing about emerging infection? BBTS 2014

What s next? Emerging infections appearing at an average rate of one per year 4. What are we doing about emerging infection? BBTS 2014 www.hpa.org.uk

What s next? A recognised infection spreading to new areas or populations The result of discovering that a known disease is caused by infection A previously unrecognised infection (eg habitat change due to deforestation) A new infection resulting from change(s) in existing microorganisms An "old" infection re-emerging because it has become resistant to treatment, or as a result of a breakdown in public health initiatives. WNV, chikungunya dengue XMRV (or not), Cycloviruses? P. knowlesi? MERS CoV? Swine flu, Avian flu Malaria, syphilis, ebola 5. What are we doing about emerging infection? BBTS 2014

What are we doing about it? NHSBT/PHE monthly list EBA alerts PHE alerts Risk assessment by SACTTI to JPAC NO action Monitor Plan Research Deferral Test www.transfusionguidelines.org.uk/document-library/position-statements/emerging-infections 6. What are we doing about emerging infection? BBTS 2014

What are we doing about it? The monthly NHSBT/PHE emerging infection list: Infection issues that may be of relevance to patient safety and/or blood and tissue availability in the UK. Sources: PHE Emerging Summary; NaTHNaC; ECDC Weekly Disease Threats; CDC; WHO; Promed; AABB news; Pubmed search; Transfusion, Transfusion medicine, Emerging infectious disease, Epidemiology and Infection, Vox Sang, NEJM, Eurosurveillance, PHE HPR, Clinical Infectious Diseases, Plos Pathogens, Plos neglected tropical diseases, Plos Outbreaks; CBBS website 7. What are we doing about emerging infection? BBTS 2014

What are we doing about it? Month Year Source Infectious agent/disease Country new/ update type of incident Comment 8 2014 Promed Babesiosis Slovenia new Human case First proven human case of babesia in Slovenia in a 55-year-old woman. Babesia in animals have been found all over Europe including Slovenia. Sample from the list of August items 8 2014 NaTHNaC Dengue France new Traveller Advice A confirmed case of locally acquired dengue fever in Southern France, Toulon, department of the Var. This is an isolated case and surveillance and vector control are underway. Aedes albopictus, is established in many parts of southern Europe including the south-eastern departments of France. The risk of travellers acquiring dengue fever in France is extremely low. 8 2014 ECDC CDTR Wk 37 8 2014 ECDC CDTR Wk 37 8 2014 ECDC CDTR Wk 37 Chikungunya (CHIKV) Americas Update Outbreak The number of reported cases of chikungunya infections is continuing to rise, in particular in Puerto Rico (USA). Colombia have reported the first four autochthonous cases. The outbreak has spread to North, Central and South America. There have been more than 660 000 probable and confirmed cases in the region, including 46 fatalities so far. Several EU countries are reporting imported cases from the affected areas. Ebola Virus Disease (EVD) West Africa Update Risk assessment The risk of infection is considered very low if precautions are strictly followed however the likelihood of visitors and travellers coming into contact with ill persons is increasing due to the increase in the number of new EVD cases in recent weeks, the urban transmission, and the fact that not all chains of transmission are known. Risk assessment 3 Sept. Flu, avian A(H7N9) China Update Surveillance No new cases of A(H7N9) have been reported since 4 September. 453 cases (175 deaths) have been reported since March 2013. No autochthonous cases have been reported from outside of China. Most cases have been unlinked, and sporadic zoonotic transmission from poultry to humans is the most likely explanation for the outbreak which peaked during the winter of 2013-2014. Imported cases of influenza A(H7N9) may be detected in Europe. However, the risk of the disease spreading among humans following an importation to Europe is considered to be very low. 8 2014 NaTHNaC MERS-CoV (Middle East respiratory syndrome coronavirus) Kingdom of Saudi Arabia (KSA) Update Traveller Advice The 1435 Hajj season is estimated to fall in early October 2014. The Ministry of Health KSA recommends that elderly people, pregnant women, children, and those with chronic diseases postpone their Hajj and Umrah rituals for this year for their own safety. As well as MERS Co-V other infections could be present eg hepatitis B and rabies. Malaria is not present in Medina or Makkah [Mecca], but malaria is a risk in the south-western provinces of Saudi Arabia if onward travel is planned. 8 2014 ECDC CDTR Wk 37 WNV Europe Update Surveillance As of 11 September 2014, 37 human cases of West Nile fever have been reported in the EU: Greece (13), Italy (8), Romania (13), Hungary (2) and Austria (1). 77 cases have been reported in neighbouring countries: Bosnia and Herzegovina (13), Serbia (38) Russia (24 cases in the following oblasts: Saratovskaya (9), Samarskaya (6), Volgogradskaya (3), Astrakhanskaya (3), Belgorodskaya (1), Altayskiy Kray (1) and Chelyabinskaya (1). Israel (2). Spain and Turkey have both reported 1 case of WNV in a horse. [Not all regions in Russia covered by the GDRI] 8. What are we doing about emerging infection? BBTS 2014

What are we doing about it? Risk Assessments by SACTTI blood-borne agent? prevalence in the donor population? asymptomatic stage? survive processing/ storage? known to be transmitted by blood/ tissues/ organs? outcome of infection: immunosuppression? screening tests available? is testing warranted? other safety measures? e.g., deferral 9. What are we doing about emerging infection? BBTS 2014

What are we doing about it? What are other countries finding/considering? Lieshout-Krikke et al. Travel behavior and deferral of Dutch blood donors: consequences for donor availability. Transfusion. 2014 Jul 22. Offergeld et al. Sexual risk behaviour and donor deferral in Europe. Vox Sang. 2014 Jul 17. Petersen & Epstein. Chikungunya virus: new risk to transfusion safety in the Americas TRANSFUSION 2014;54:1911-1915. Hogema et al. Past and present of hepatitis E in the Netherlands. Transfusion 10. What are we doing about emerging infection? BBTS 2014

What are we doing about it? EUFRAT European Up Front Risk Assessment Tool Useful in outbreak situation... 11. What are we doing about emerging infection? BBTS 2014 Transfusion 2013 Jul;53(7):1421-8

What are we doing about Flu? Monitor (pathogenicity, transmissability, young people!) Risk Assessment Pandemic planning National PH initiatives Wash your hands! Get the flu jab! 12. What are we doing about emerging infection? BBTS 2014

What are we doing about Ebola? Monitor: huge influx of info and anxiety 21 day incubation, present as fever and D&V Gets more infectious as symptoms progress Bushmeat, direct H2H NOT airborne Risk assessment: LOW RISK with ongoing monitoring, discussions and advice for H+S, labs (current donor selection guidelines (fever, malaria) http://nhsbtweb/userfiles/ebola%20virus%20outbreak_advice%20for%20nhsbt_august2014_.pdf 13. What are we doing about emerging infection? BBTS 2014

What are we doing about Ebola? The UK government is closely monitoring the spread of the Ebola virus in West Africa. Should I be worried about this outbreak? (NHS Choices) Advice for health professionals in the UK What are the arrangements at the UK border? Travel advice Government actions to help affected countries Play your part in the UK s fight against Ebola 14. What are we doing about emerging infection? BBTS 2014 www.gov.uk

What are we doing about MERS-CoV? Monitor Risk Assessment: period of asymptomatic viraemia? intermediate host? deferral period post infection? keep international situation under close observation. Evidence, UK Blood Donor Survey: travel Q 15. What are we doing about emerging infection? BBTS 2014

What are we doing about Chikungunya? Chikungunya outbreak in the Caribbean 1st documented locally acquired transmission of chikungunya virus in the Americas Popular travel destination for EU residents Viraemic asymptomatic returning travellers could in theory transmit via blood donation 15 travel-associated cases of chikungunya reported in England, Wales and NI in 2012 Up to 10% of cases experience arthritis, chronic joint pain and fatigue MONITOR and Risk assess. Impact on deferrals? 16. What are we doing about emerging infection? BBTS 2014

What are we doing about HEV? TTI Risk assessment: monitor and further evidence Seroprevalence in donors (Beale et al 2011 Vox) SABTO risk assessment Spring 2015 2004 2011 2013 2015 Increasing evidence that HEV (genotype 3) is locally acquired in Western industrial countries. HEV 1&2 travel associated. Increase in TTIs to investigateproven cases identified Research study: HEV units released and transmit but no lasting effect seen to date (Hewitt et al. Lancet 2014) 17. What are we doing about emerging infection? BBTS 2014

What are we doing about WNV? www.transfusionguidelines.org.uk/document-library/position-statements/west-nile-virus-wnv 18. What are we doing about emerging infection? BBTS 2014

False alarm! 19. What are we doing about emerging infection? BBTS 2014

What are we doing about emerging infections? CONCLUSION The UK Blood Services are constantly: scanning for emerging infectious threats reacting to outbreaks (even if no action required) (re)assessing risk producing new evidence (research, surveillance) planning future strategies (deferrals- 4 wk?, tropical? testing, PI?) 20. What are we doing about emerging infection? BBTS 2014